Darling Ingredients Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Darling Ingredients Inc. Common Stock trades at $61.54 (market cap $9.82B), while Halozyme Therapeutics Inc. Common Stock trades at $112.53 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Darling Ingredients Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Darling Ingredients Inc. Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| DAR | HALO | |
|---|---|---|
Market Cap | $9.82B | $12.58B |
Volume | 2,815,184 | 2,179,278 |
Sector | Consumer Staples | Health |
52-Week High | $68.34 | $115.22 |
52-Week Low | $29.91 | $61.63 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $13.83B | $14.49B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Darling Ingredients collects and processes used cooking oil, animal by-products, and food waste. It produces ingredients and renewable fuel feedstocks from these materials.
Read more on DAR →Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →